SynthesisFrontiers in psychiatry2025
The impact of mobile health interventions on patients with schizophrenia: a meta-analysis.
Synthesis in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically evaluate the impact of mobile health (mHealth) interventions on patients with schizophrenia. Methods: Randomized controlled trials (RCTs) concerning the effects of mHealth interventions on patients with schizophrenia were retrieved from databases including CNKI, WanFang, VIP, CBM, PubMed, Cochrane Library, Embase, and Web of Science from their inception until September 2025. Data analysis was performed using RevMan 5.4 software. Results: A total of 10 RCTs involving 1135 patients with schizophrenia were included. The analysis results showed that the intervention group was significantly better than the control group in improving positive symptoms of schizophrenia ( Conclusion: mHealth interventions demonstrate a slight but definite positive effect on improving positive symptoms in schizophrenia. However, they show no significant effect on improving depressive symptoms. While a higher incidence of adverse events was reported in the intervention group, this finding should be interpreted with caution as it may be influenced by enhanced detection through digital monitoring (surveillance bias).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.